About Advalytix AG
Advalytix provides cell-based molecular diagnostics with main focus is the miniaturization of diagnostic and biological tests for RD. It was initially a Cipio Partner portfolio company and later from 2005 was a wholly owned subsidiary of Olympus Life and Material Science Europa. Its products link imaging technologies such as microscopy with nucleic acid analysis, enabling to offer turnkey system solutions consisting of both instruments and reagents. It was acquired by Beckman coulter in 2009 and is currently a team within Beckman Coulter Genomics.
- Headquarter Munchen, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Beckman Coulter
(Jun 01, 2009)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Advalytix AG
Detailed funding history for Advalytix AG
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Advalytix AG
Advalytix AG has secured backing from 1 investor. Prominent investors backing the company include Beckman Coulter.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Clinical diagnostic products are manufactured for biomedical testing.
|
Locked | Locked | Locked |
Investor details for Advalytix AG
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Advalytix AG
Investment portfolio details for Advalytix AG
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Advalytix AG
Detailed financials for Advalytix AG
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Advalytix Ag Comparisons
Peer comparison for Advalytix AG
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Advalytix AG
Detailed competitors of Advalytix AG
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Advalytix Ag
Complete news archive for Advalytix AG
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Advalytix AG
Advalytix AG was founded in 2000.
Advalytix AG is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Advalytix provides cell-based molecular diagnostics with main focus is the miniaturization of diagnostic and biological tests for RD. It was initially a Cipio Partner portfolio company and later from 2005 was a wholly owned subsidiary of Olympus Life and Material Science Europa. Its products link imaging technologies such as microscopy with nucleic acid analysis, enabling to offer turnkey system solutions consisting of both instruments and reagents. It was acquired by Beckman coulter in 2009 and is currently a team within Beckman Coulter Genomics.
Advalytix AG has 1 investor. Key investors include Beckman Coulter.